Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Advanced Non-Small Cell Lung Cancer
NCT00005989Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2002
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in non-small cell lung cancer (NSCLC), sponsored by Mayo Clinic. Started Nov 2002; status: completed.
02
Drugs
tipifarnib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005989.